GlobalData on MSN10d
Cocrystal to extend enrolment in Phase IIa influenza inhibitor trialCocrystal Pharma has announced its intent to extend enrolment for its Phase IIa human challenge trial of CC-42344 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback